Swander Pace gets about 8x EBITDA for Insight Pharma
Swander Pace Capital has closed its sale of over-the-counter pharmacy products maker Insight Pharmaceuticals to Prestige Brands for $750 million after growing the over-the-counter owner drug store maker’s revenue by 2.5x in five years.
8 September 2014•1 min read
